INBX – inhibrx, inc. (US:NASDAQ)
Stock Stats
News
Inhibrx Announces Participation in Upcoming Scientific Conference [Yahoo! Finance]
Inhibrx Announces Participation in Upcoming Scientific Conference
Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight [Yahoo! Finance]
Inhibrx Biosciences (NASDAQ:INBX) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too [Seeking Alpha]
Form 8-K Inhibrx Biosciences, For: Feb 23
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: MORGAN STANLEY
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: BlackRock, Inc.
Form 8-K Inhibrx Biosciences, For: Dec 16
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.